Zhang Zhen-Rong, Li Yang-Zheng, Wu Xiao-Qing, Chen Wen-Jun, Yuan Jie-Yang, Yan Min
Department of Rehabilitation Medicine, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, No. 3 Qingchun East Road, Hangzhou, Zhejiang, 310000, China.
BMC Cardiovasc Disord. 2025 Apr 18;25(1):299. doi: 10.1186/s12872-025-04754-0.
Standardized tools are needed to accurately assess the severity of postoperative complications in cardiac surgery, which is critical for patient management and outcome evaluation. This study aims to evaluate the application of the Clavien Dindo Complications Classification (CDCC) and Comprehensive Complications Index (CCI) in cardiac surgery.
563 patients (76.3%) had at least one complication. The mean CCI was 22.5 ± 19.3. Patients who underwent more complex surgeries had higher CDCC grades and CCI scores. Hospitalization cost and length of stay increased with increasing CDCC grade and CCI score. The ACCI (OR: 1.334 [1.109-1.606], p = 0.002) and LVEF (OR: 0.965 [0.943-0.987], p = 0.002) were associated factors for the most severe complications. The CCI may reduce the required sample size by 20.5 times and 19.6 times compared with the most severe complication or major adverse cardiovascular and cerebrovascular events, respectively, as an endpoint.
The CCI and CDCC can help reflect the complexity of cardiac surgery and the burden of hospitalization, providing a more accurate assessment of surgical complications. This may reduce the sample size needed for clinical trials, thus facilitating research in cardiac surgery.
Chinese Clinical Trial Registry (No. ChiCTR2400084925) on May 28th, 2024. https://www.chictr.org.cn/showproj.html?proj=228499 .
需要标准化工具来准确评估心脏手术术后并发症的严重程度,这对患者管理和结果评估至关重要。本研究旨在评估Clavien-Dindo并发症分类(CDCC)和综合并发症指数(CCI)在心脏手术中的应用。
563例患者(76.3%)至少发生了一种并发症。平均CCI为22.5±19.3。接受更复杂手术的患者CDCC分级和CCI评分更高。住院费用和住院时间随着CDCC分级和CCI评分的增加而增加。ACCI(比值比:1.334[1.109 - 1.606],p = 0.002)和LVEF(比值比:0.965[0.943 - 0.987],p = 0.002)是最严重并发症的相关因素。与分别以最严重并发症或主要不良心血管和脑血管事件作为终点相比,CCI作为终点时所需样本量可能分别减少20.5倍和19.6倍。
CCI和CDCC有助于反映心脏手术的复杂性和住院负担,提供更准确的手术并发症评估。这可能减少临床试验所需的样本量,从而促进心脏手术研究。
中国临床试验注册中心(编号ChiCTR2400084925),2024年5月28日。https://www.chictr.org.cn/showproj.html?proj=228499 。